2019
|
Invention
|
N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use. The present invention pro... |
|
Invention
|
Substituted pyrrolidines and methods of use.
The invention discloses compounds of Formula (I)
... |
|
Invention
|
Substituted pyrrolidines and their use. The invention discloses compounds of Formula (I) wherein ... |
|
Invention
|
N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use.
The present invention pr... |
|
Invention
|
Substituted tricyclics and method of use.
The present invention provides for compounds of formul... |
2018
|
Invention
|
Heteroaryl substituted pyridines and methods of use. The invention discloses compounds of Formula... |
|
Invention
|
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use.... |
2017
|
Invention
|
Deuterated cftr modulators and methods of use.
The invention discloses compounds of Formula (I)
... |
|
Invention
|
Deuterated cftr modulators and methods of use. The invention discloses compounds of Formula (I), ... |
|
Invention
|
N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use. The present invention pro... |
|
Invention
|
Compounds and pharmaceutical compositions thereof for use in the treatment of cystic fibrosis. Th... |
|
Invention
|
Substituted pyrrolidines and their use in the treatment of cystic fiibrosis. The invention disclo... |
|
Invention
|
Substituted pyrrolidines as cftr modulators. The invention discloses compounds of Formula (I) whe... |
|
Invention
|
Substituted pyrrolidines and methods of use. The invention discloses compounds of Formula (I)
5 ... |
|
Invention
|
Modulators of cystic fibrosis transmembrane conductance regulator protein. The present invention ... |
|
Invention
|
Substituted chromanes and method of use.
The invention provides for compounds of formula (I)
T... |
2016
|
Invention
|
Potentiator-corrector combinations useful in the treatment of cystic fibrosis. A combination ther... |
|
Invention
|
Substituted pyrazolo[3,4-b]pyridin-6-carboxylic acids and their use. The present invention provid... |
|
Invention
|
Compounds for treatment of cystic fibrosis. A corrector agent capable of stabilizing a newly synt... |
|
Invention
|
Compounds for treatment of cystic fibrosis. A corrector agent capable of stabilizing a newl... |
|
Invention
|
Potentiator-corrector combinations useful in the treatment of cystic fibrosis.
A combination the... |
|
Invention
|
Novel compounds for treatment of cystic fibrosis. A corrector agent capable of stabilizing a newl... |
|
Invention
|
Substituted tricyclics and method of use. The present invention provides for compounds of formula... |
|
Invention
|
Substituted pyridines and method of use. The invention discloses compounds of Formula (I) wherein... |
2015
|
Invention
|
Substituted tetrahydropyrans and method of use. Compounds of formula (I) and pharmaceutically acc... |
|
Invention
|
Substituted chromanes and method of use. The invention provides for compounds of formula (I), whe... |